pubmed.ncbi.nlm.nih.gov

Regulation of (pro)renin receptor expression by glucose-induced mitogen-activated protein kinase, nuclear factor-kappaB, and activator protein-1 signaling pathways - PubMed

Regulation of (pro)renin receptor expression by glucose-induced mitogen-activated protein kinase, nuclear factor-kappaB, and activator protein-1 signaling pathways

Jiqian Huang et al. Endocrinology. 2010 Jul.

Abstract

Renal (pro)renin receptor (PRR) expression is increased in diabetes. The exact mechanisms involved in this process are not well established. We hypothesized that high glucose up-regulates PRR through protein kinase C (PKC)-Raf-ERK and PKC-c-Jun N-terminal kinase (JNK)-c-Jun signaling pathways. Rat mesangial cells exposed to 30 mm d-glucose demonstrated significant increase in PRR mRNA and protein expression, intracellular phosphorylation of Raf-1 (Y340/341), ERK, JNK, nuclear factor-kappaB (NF-kappaB) p65 (S536) and c-Jun (S63). By chromatin immunoprecipitation assay and EMSA, high glucose induced more functional NF-kappaB and activator protein (AP)-1 dimers bound to corresponding cis-regulatory elements in the predicted PRR promoter to up-regulate PRR transcription. Conventional and novel PKC inhibitors Chelerythrine and Rottlerin, Raf-1 inhibitor GW5074, MEK1/2 inhibitor U0126, JNK inhibitor SP600125, NF-kappaB inhibitor Quinazoline, and AP-1 inhibitor Curcumin, respectively, attenuated glucose-induced PRR up-regulation. Chelerythrine and Rottlerin also inhibited glucose-induced phosphorylation of Raf-1 (Y340/341), ERK1/2, JNK, NF-kappaB p65 (S536), and c-Jun (S63). GW5074 and U0126 inhibited the phosphorylation of ERK1/2 and NF-kappaB p65 (S536). SP600125 inhibited phosphorylation of NF-kappaB p65 (S536) and c-Jun (S63). We conclude that high glucose up-regulates the expression of PRR through mechanisms dependent on both PKC-Raf-ERK and PKC-JNK-c-Jun signaling pathways. NF-kappaB and AP-1 are involved in high-glucose-induced PRR up-regulation in rat mesangial cells.

PubMed Disclaimer

Figures

**Figure 1**
PRR promoter prediction, mapping of NF-κB and AP-1 regulatory elements, and designs of ChIP primers and EMSA probes. Sp1, AP-1, and NF-κB elements in PRR promotor are designated with *large capital letters A–G*. EMSA probes corresponding to A–G elements were labeled as NF-κB01-02, AP-1.1-1.4, and Sp1, respectively. Position and orientation of ChIP primers corresponding to different A–G elements were labeled with *black arrows* and *dashed lines*. F, Forward primer; R, reverse primer.

**Figure 2**
Effect of glucose and different intracellular signaling pathways on PRR expression. A, Inhibition of PKC with *Chelerythrine (Che*; 5 μ
m
) and *Rottlerin (Ro*; 5 μ
m
). B, Inhibition of MAPKs with *U0126* (10 μ
m
) and *SP600125* (20 μ
m
). C, Inhibition of Raf-1 with *GW5074* (10 n
m
). D, Inhibition of AP-1 with *Curcumin* (100 μ
m
). E, Inhibition of NF-κB with *Quinazoline* (NF-κBi) (10 μ
m
). Control, 5 m
m d
-glucose+25 m
m l
-glucose; glucose, 30 m
m d
-glucose. All the results represent the average of three independent experiments and each experiment was repeated at least three times.

**Figure 3**
PKC isomer proteins and their translocation, phosphorylation of intracellular signal proteins in response to high glucose alone, and combined with different kinases inhibitors in RMCs. Panel A, PKC isomers in membranous (M), cytosolic (C), and nuclear (N) compartments. Loading control (LC), β-Actin for membranous and cytosolic fractions and TATA binding protein (TBP) for nuclear fraction. Panels B–D, Phosphorylation of intracellular signal proteins in response to high glucose alone and combined with different kinases inhibitors. After 2 wk of glucose exposure and 12 h of serum starvation, cells were exposed to inhibitors for 15, 30, and 60 min. Panel B, PKC inhibition and phosphorylation of Raf-1, ERK1/2, JNK, c-Jun, and NF-κB p65. Panel C, Raf-1 inhibition and phosphorylation of ERK1/2, JNK, c-Jun, and NF-κB p65. Panel D, MEK1/2 and JNK inhibition and phosphorylation of NF-κB p65 and c-Jun. Control, 5 m
m d
-glucose+25 m
m l
-glucose; glucose, 30 m
m d
-glucose. The results are representative of three independent experiments.

**Figure 4**
Effect of glucose on binding of AP-1 regulatory elements in predicted PRR promoter. Panels A–D, *In vivo* mapping of AP-1 by ChIP. Panel E, EMSA and competitive EMSA. Oligo, AP-1 probes to AP-1 binding elements (Panels C–F as shown in Fig. 1). NE, Nuclear extract. Glucose (−), Control (5 m
m d
-glucose+25 m
m l
-glucose); glucose (+), 30 m
m d
-glucose. ChIP assay is based on three independent experiments and EMSA is a representative of three experiments.

**Figure 5**
Effect of glucose on binding of NF-κB and Sp1/Sp3 regulatory elements in predicted PRR promoter. Panels A and B, *In vivo* mapping of NF-κB by ChIP. Panel C, NF-κB EMSA and competitive EMSA. Panels D and E, *In vivo* mapping of Sp1 and Sp3 by ChIP. F, Sp1/Sp3 EMSA and competitive EMSA. Oligo, NF-κB probes to NF-κB binding elements A and B and Sp1 probes to Sp1 or Sp3 binding elements G as shown in Fig. 1. NE, Nuclear extract. Glucose (−), Control (5 m
m d
-glucose + 25 m
m l
-glucose); glucose (+), 30 m
m d
-glucose. ChIP assay is based on three independent experiments and EMSA is a representative of three experiments.

**Figure 6**
Working model of AP-1, NF-κB, and Sp1/Sp3 in predicted PRR promoter. *Large open* and *solid black arrows* refer to constitutive and regulated expression, respectively.

Cited by

Interaction of the renin angiotensin and cox systems in the kidney.
Quadri SS, Culver SA, Li C, Siragy HM. Quadri SS, et al. Front Biosci (Schol Ed). 2016 Jun 1;8(2):215-26. doi: 10.2741/s459. Front Biosci (Schol Ed). 2016. PMID: 27100703 Free PMC article. Review.
The critical role of the central nervous system (pro)renin receptor in regulating systemic blood pressure.
Xu Q, Jensen DD, Peng H, Feng Y. Xu Q, et al. Pharmacol Ther. 2016 Aug;164:126-34. doi: 10.1016/j.pharmthera.2016.04.006. Epub 2016 Apr 23. Pharmacol Ther. 2016. PMID: 27113409 Free PMC article. Review.
Cannabinoid receptor 1 disturbance of PPARγ2 augments hyperglycemia induction of mesangial inflammation and fibrosis in renal glomeruli.
Lin CL, Hsu YC, Lee PH, Lei CC, Wang JY, Huang YT, Wang SY, Wang FS. Lin CL, et al. J Mol Med (Berl). 2014 Jul;92(7):779-92. doi: 10.1007/s00109-014-1125-6. Epub 2014 Apr 11. J Mol Med (Berl). 2014. PMID: 24722948
High glucose induces podocyte injury via enhanced (pro)renin receptor-Wnt-β-catenin-snail signaling pathway.
Li C, Siragy HM. Li C, et al. PLoS One. 2014 Feb 12;9(2):e89233. doi: 10.1371/journal.pone.0089233. eCollection 2014. PLoS One. 2014. PMID: 24533170 Free PMC article.
(Pro)renin receptor contributes to regulation of renal epithelial sodium channel.
Quadri S, Siragy HM. Quadri S, et al. J Hypertens. 2016 Mar;34(3):486-94; discussion 494. doi: 10.1097/HJH.0000000000000825. J Hypertens. 2016. PMID: 26771338 Free PMC article.

References

1. Carey RM, Siragy HM 2003 The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol Metab 14:274–281 - PubMed
1. Carey RM, Siragy HM 2003 Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 24:261–271 - PubMed
1. Nguyen G, Delarue F, Berrou J, Rondeau E, Sraer JD 1996 Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int 50:1897–1903 - PubMed
1. Nguyen G, Delarue F, Burcklé C, Bouzhir L, Giller T, Sraer JD 2002 Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109:1417–1427 - PMC - PubMed
1. Ludwig J, Kerscher S, Brandt U, Pfeiffer K, Getlawi F, Apps DK, Schägger H 1998 Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton- ATPase from chromaffin granules. J Biol Chem 273:10939–10947 - PubMed

Regulation of (pro)renin receptor expression by glucose-induced mitogen-activated protein kinase, nuclear factor-kappaB, and activator protein-1 signaling pathways - PubMed